These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Transposable elements (TEs) contribute to stress-related long intergenic noncoding RNAs in plants. Wang D; Qu Z; Yang L; Zhang Q; Liu ZH; Do T; Adelson DL; Wang ZY; Searle I; Zhu JK Plant J; 2017 Apr; 90(1):133-146. PubMed ID: 28106309 [TBL] [Abstract][Full Text] [Related]
23. More to the RAS Story: KRAS Lietman CD; Johnson ML; McCormick F; Lindsay CR Am Soc Clin Oncol Educ Book; 2022 Apr; 42():1-13. PubMed ID: 35561303 [TBL] [Abstract][Full Text] [Related]
24. Cell-type specific tumorigenesis with Ras oncogenes in human lung epithelial cells. Kumazaki M; Shimomura I; Kiyono T; Ochiya T; Yamamoto Y Biochem Biophys Res Commun; 2020 Apr; 525(2):483-490. PubMed ID: 32111352 [TBL] [Abstract][Full Text] [Related]
26. Oncogenic KRAS activates hedgehog signaling pathway in pancreatic cancer cells. Ji Z; Mei FC; Xie J; Cheng X J Biol Chem; 2007 May; 282(19):14048-55. PubMed ID: 17353198 [TBL] [Abstract][Full Text] [Related]
27. MUC1-C confers EMT and KRAS independence in mutant KRAS lung cancer cells. Kharbanda A; Rajabi H; Jin C; Alam M; Wong KK; Kufe D Oncotarget; 2014 Oct; 5(19):8893-905. PubMed ID: 25245423 [TBL] [Abstract][Full Text] [Related]
28. Wilms tumor 1 (WT1) regulates KRAS-driven oncogenesis and senescence in mouse and human models. Vicent S; Chen R; Sayles LC; Lin C; Walker RG; Gillespie AK; Subramanian A; Hinkle G; Yang X; Saif S; Root DE; Huff V; Hahn WC; Sweet-Cordero EA J Clin Invest; 2010 Nov; 120(11):3940-52. PubMed ID: 20972333 [TBL] [Abstract][Full Text] [Related]
29. D154Q Mutation does not Alter KRAS Dimerization. Grozavu I; Stuart S; Lyakisheva A; Yao Z; Pathmanathan S; Ohh M; Stagljar I J Mol Biol; 2022 Jan; 434(2):167392. PubMed ID: 34896362 [TBL] [Abstract][Full Text] [Related]
30. Circular RNAs are down-regulated in KRAS mutant colon cancer cells and can be transferred to exosomes. Dou Y; Cha DJ; Franklin JL; Higginbotham JN; Jeppesen DK; Weaver AM; Prasad N; Levy S; Coffey RJ; Patton JG; Zhang B Sci Rep; 2016 Nov; 6():37982. PubMed ID: 27892494 [TBL] [Abstract][Full Text] [Related]
34. Oncogenic KRAS-associated gene signature defines co-targeting of CDK4/6 and MEK as a viable therapeutic strategy in colorectal cancer. Pek M; Yatim SMJM; Chen Y; Li J; Gong M; Jiang X; Zhang F; Zheng J; Wu X; Yu Q Oncogene; 2017 Aug; 36(35):4975-4986. PubMed ID: 28459468 [TBL] [Abstract][Full Text] [Related]
35. Genome-wide DNA methylation analysis of KRAS mutant cell lines. Tew BY; Durand JK; Bryant KL; Hayes TK; Peng S; Tran NL; Gooden GC; Buckley DN; Der CJ; Baldwin AS; Salhia B Sci Rep; 2020 Jun; 10(1):10149. PubMed ID: 32576853 [TBL] [Abstract][Full Text] [Related]
36. A requirement for wild-type Ras isoforms in mutant KRas-driven signalling and transformation. Bentley C; Jurinka SS; Kljavin NM; Vartanian S; Ramani SR; Gonzalez LC; Yu K; Modrusan Z; Du P; Bourgon R; Neve RM; Stokoe D Biochem J; 2013 Jun; 452(2):313-20. PubMed ID: 23496764 [TBL] [Abstract][Full Text] [Related]
37. Oncogenic KRAS regulates miR-200c and miR-221/222 in a 3D-specific manner in colorectal cancer cells. Tsunoda T; Takashima Y; Yoshida Y; Doi K; Tanaka Y; Fujimoto T; Machida T; Ota T; Koyanagi M; Kuroki M; Sasazuki T; Shirasawa S Anticancer Res; 2011 Jul; 31(7):2453-9. PubMed ID: 21873159 [TBL] [Abstract][Full Text] [Related]
38. KRAS Zhou ZW; Ambrogio C; Bera AK; Li Q; Li XX; Li L; Son J; Gondi S; Li J; Campbell E; Jin H; Okoro JJ; Xu CX; Janne PA; Westover KD Cancer Res; 2020 Sep; 80(17):3719-3731. PubMed ID: 32605999 [TBL] [Abstract][Full Text] [Related]
39. KRAS mutant rectal cancer cells interact with surrounding fibroblasts to deplete the extracellular matrix. Kim JK; Marco MR; Choi SH; Qu X; Chen CT; Elkabets M; Fairchild L; Chow O; Barriga FM; Dow LE; O'Rourke K; Szeglin B; Yarilin D; Fujisawa S; Manova-Todorova K; Paty PB; Shia J; Leslie C; Smith JJ; Lowe S; Pelossof R; Sanchez-Vega F; Garcia-Aguilar J Mol Oncol; 2021 Oct; 15(10):2766-2781. PubMed ID: 33817986 [TBL] [Abstract][Full Text] [Related]
40. Effect of KRAS oncogene substitutions on protein behavior: implications for signaling and clinical outcome. Ihle NT; Byers LA; Kim ES; Saintigny P; Lee JJ; Blumenschein GR; Tsao A; Liu S; Larsen JE; Wang J; Diao L; Coombes KR; Chen L; Zhang S; Abdelmelek MF; Tang X; Papadimitrakopoulou V; Minna JD; Lippman SM; Hong WK; Herbst RS; Wistuba II; Heymach JV; Powis G J Natl Cancer Inst; 2012 Feb; 104(3):228-39. PubMed ID: 22247021 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]